Subclonal STAT3 mutations solidify clonal dominance
Authors:
- Cassandra M. KerrCKCassandra M. Kerr
- Michael J. ClementeMCMichael J. Clemente
- Peter W. ChomczynskiPCPeter W. Chomczynski
- Yasunobu NagataYNYasunobu Nagata
- Vera AdemaVAVera Adema
- Valeria VisconteValeria Visconte
- Satu MustjokiSMSatu Mustjoki
- Tomas RadivoyevitchTRTomas Radivoyevitch
- Mikkael A. SekeresMSMikkael A. Sekeres
- Jaroslaw P. MaciejewskiJMJaroslaw P. Maciejewski
Open Access
- 21 March 2019
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 3 (6) , 917-921
Abstract
T large granular lymphocyte leukemia (T-LGLL) is a clonal lymphoproliferative disorder that can arise in the context of pathologic or physiologic cytotoxic T-cell (CTL) responses. STAT3 mutations are often absent in typical T-LGLL, suggesting that in a significant fraction of patients, antigen-driven expansion alone can maintain LGL clone persistence. We set out to determine the relationship between activating STAT3 hits and CTL clonal selection at presentation and in response to therapy. Thus, a group of patients with T-LGLL were serially subjected to deep next-generation sequencing (NGS) of the T-cell receptor (TCR) Vβ complementarity-determining region 3 (CDR3) and STAT3 to recapitulate clonal hierarchy and dynamics. The results of this complex analysis demonstrate that STAT3 mutations produce either a sweeping or linear subclone within a monoclonal CTL population either early or during the course of disease. Therapy can extinguish a LGL clone, silence it, or adapt mechanisms to escape elimination. LGL clones can persist on elimination of STAT3 subclones, and alternate STAT3-negative CTL clones can replace therapy-sensitive CTL clones. LGL clones can evolve and are fueled by a nonextinguished antigenic drive. STAT3 mutations can accelerate this process or render CTL clones semiautonomous and not reliant on physiologic stimulation. Key Points TCR clones can be followed throughout the disease course with deep NGS sequencing of the TCR Vβ CDR3 and STAT3. Visual AbstractKeywords
This publication has 18 references indexed in Scilit:
- Deep sequencing of the T-cell receptor repertoire in CD8+ T-large granular lymphocyte leukemia identifies signature landscapesBlood, 2013
- STAT3 mutations are highly specific for large granular lymphocytic leukemiaLeukemia, 2012
- STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemiaBlood, 2012
- SomaticSTAT3Mutations in Large Granular Lymphocytic LeukemiaNew England Journal of Medicine, 2012
- Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemiaBlood, 2011
- How I treat LGL leukemiaBlood, 2011
- T-large granular lymphocyte leukemia: current molecular conceptsHematology, 2006
- Large Granular Lymphocyte LeukemiaThe Oncologist, 2006
- Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expressionJournal of Clinical Investigation, 2001
- Leukemia of Large Granular Lymphocytes: Association with Clonal Chromosomal Abnormalities and Autoimmune Neutropenia, Thrombocytopenia, and Hemolytic AnemiaAnnals of Internal Medicine, 1985